Wrapping Up Cellomics Buy, Fisher Appears Unlikely to Integrate Business Segments | GenomeWeb

Though it has been steadily adding an array of businesses to bolster its molecular biology platforms over the past few years, Fisher Scientific has not made a move to integrate those pieces.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.